SGNI — StemGen Income Statement

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro Cap

Annual income statement for StemGen, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2017 June 30th	2018 June 30th	2019 June 30th	2020 June 30th	2021 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	0.022	0.019	0.039
Cost of Revenue
Gross Profit	—	—	0.014	0.011	0.009
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0	-0.098	0.265	0.086	0.283
Operating Profit	0	0.098	-0.243	-0.067	-0.244
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.07	0.006	-0.426	-0.231	-0.433
Net Income After Taxes	-0.07	0.006	-0.426	-0.231	-0.433
Net Income Before Extraordinary Items
Net Income	-0.07	0.006	-0.426	-0.231	-0.433
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.07	0.006	-0.426	-0.231	-0.433
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.005	-0.009	-0.017	-0.005	-0.009